22Dec 2022
Response and Adverse Event Rates With Placebo in Gastroparesis: A Systematic Review and Meta-analysis

Response and Adverse Event Rates With Placebo in Gastroparesis: A Systematic Review and Meta-analysis

Multiple drugs have been used to treat gastroparesis symptoms, yet their therapeutic benefits are poorly understood partly due to lack of insight into response and adverse event rates with placebo in randomized controlled trials (RCTs). We evaluated these issues systematically in drug trials for gastroparesis. This meta-analysis assessed placebo response and adverse event rates in gastroparesis. To accurately assess therapeutic gain, future trials should be a minimum of 8 weeks duration, use validated questionnaires, and distinguish gastroparesis subtypes.

  • #gastroenterology

Like

Save

Share